956345

Pierre Fabre Pharmaceuticals, Inc. — FEI 3013144400

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 30, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Parsippany, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report